Quarterly ResultJun 12, 2026, 05:16 PM
Odyssey Health Reports Wider Nine-Month Net Loss, Positive Q3 Income
AI Summary
Odyssey Health, Inc. filed its unaudited quarterly report (10-Q) for the period ending April 30, 2026. The company reported a net loss of $3,319,181 for the nine months ended April 30, 2026, an increase from the $1,490,775 loss in the prior year. However, the company saw a positive swing in the third quarter, reporting a net income of $765,890 compared to a net loss of $251,743 in the same quarter last year. Despite an increase in total assets, liabilities have also grown significantly, leading to a wider stockholders' deficit. The company continues to face going concern issues.
Key Highlights
- Odyssey Health reported a net loss of $3,319,181 for the nine months ended April 30, 2026, compared to a net loss of $1,490,775 for the same period in 2025.
- For the three months ended April 30, 2026, the company reported a net income of $765,890, a significant improvement from a net loss of $251,743 in the prior year's quarter.
- Total assets increased to $373,779 as of April 30, 2026, from $49,723 as of July 31, 2025.
- Total current liabilities rose to $10,123,436 as of April 30, 2026, from $7,004,421 as of July 31, 2025.
- Stockholders' deficit widened to $9,749,657 as of April 30, 2026, from $6,954,698 as of July 31, 2025.
- Cash used in operating activities was $886,778 for the nine months ended April 30, 2026.
- The company has substantial doubt about its ability to continue as a going concern due to recurring losses and negative working capital.
Price Impact
More from ODYY